{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:39:01Z","timestamp":1772120341438,"version":"3.50.1"},"reference-count":54,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Introduction: Pelvic exenteration (PEx) was first described in the 1940s as a palliative procedure in managing cervical cancer. Since then, advancements in perioperative care have transformed the options available to patients. This highly morbid procedure now offers a \u201ccure\u201d in a select cohort of patients with locally advanced and recurrent pelvic cancers. The large volume of literature in this field has resulted in a heterogeneity of data reporting, making comparative analysis extremely difficult. As such, we set out to examine the current literature and identify currently reported outcomes to guide development of a core information set (CIS) for data reporting for PEx in non-rectal cancers. Methods: A systematic review was carried out. Studies reporting on outcomes following PEx for advanced and recurrent gynecological, urological, and other non-rectal malignancies were included. Standardized outcomes were extracted and mapped to pre-determined domains. Results: Forty-four studies were found to meet our inclusion criteria. A total of 1735 data elements (DEs) were extracted verbatim, and these were assimilated into 111 standard DEs across nine domains. A wide range of reporting frequencies was observed, with the pathological domain containing the highest overall frequencies of DE reporting. Conversely, patient-reported and functional outcomes were noted to be the domain with the lowest frequency. Conclusions: This review highlights recent trends of increased reporting in the field of PEx and how this had invariably resulted in heterogeneous data reporting. We aim to guide the development of a CIS for reporting in non-rectal pelvic malignancies to help standardize future reporting.<\/jats:p>","DOI":"10.3390\/cancers17183049","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T09:32:32Z","timestamp":1758187952000},"page":"3049","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Defining Standard Data Reporting in Pelvic Exenterations for Non-Rectal Cancers: A Systematic Review of Current Data Reporting"],"prefix":"10.3390","volume":"17","author":[{"name":"PelvEx Collaborative","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1097-0142(194807)1:2<177::AID-CNCR2820010203>3.0.CO;2-A","article-title":"Complete excision of pelvic viscera for advanced carcinoma.A one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy","volume":"1","author":"Brunschwig","year":"1948","journal-title":"Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/DCR.0000000000000839","article-title":"Pelvic Exenteration Surgery: The Evolution of Radical Surgical Techniques for Advanced and Recurrent Pelvic Malignancy","volume":"60","author":"Brown","year":"2017","journal-title":"Dis. Colon. Rectum"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/bjs5.75","article-title":"Cohort study of long-term survival and quality of life following pelvic exenteration","volume":"2","author":"Steffens","year":"2018","journal-title":"BJS Open"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"PelvEx Collaborative (2022). Contemporary Management of Locally Advanced and Recurrent Rectal Cancer: Views from the PelvEx Collaborative. Cancers, 14.","DOI":"10.3390\/cancers14051161"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Lampe, B., Luengas-W\u00fcrzinger, V., Weitz, J., Roth, S., Rawert, F., Schuler, E., Classen-von Spee, S., Fix, N., Baransi, S., and Dizdar, A. (2021). Opportunities and Limitations of Pelvic Exenteration Surgery. Cancers, 13.","DOI":"10.3390\/cancers13246162"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/archdischild-2016-312117","article-title":"Core Outcome Sets","volume":"103","author":"Webbe","year":"2018","journal-title":"Arch. Dis. Child. Educ. Pract. Ed."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Abdulrahman, G.O., Das, N., Chandrasekaran, T.V., Khot, U., Drew, P.J., Bose, P., Vet, J.N., Tofazzal, N., Roberts, S., and Lutchman Singh, K. (2022). Pelvic Exenteration for the Treatment of Locally Advanced Vulvar Cancer in South West Wales. Cancers, 14.","DOI":"10.3390\/cancers14071767"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ygyno.2012.01.031","article-title":"Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: An update on out of the box surgery","volume":"125","author":"Andikyan","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ygyno.2011.03.003","article-title":"Pelvic exenteration in gynecologic oncology: A single institution study over 20 years","volume":"122","author":"Benn","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ygyno.2005.05.034","article-title":"Pelvic exenteration for recurrent gynecologic malignancy: Survival and morbidity analysis of the 45-year experience at UCLA","volume":"99","author":"Berek","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.31083\/j.ejgo.2020.02.5040","article-title":"Surgical complications and survival after pelvic exenteration: Our experience following 60 procedures","volume":"41","author":"Szabo","year":"2020","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00404-019-05154-4","article-title":"Pelvic exenteration as ultimate ratio for gynecologic cancers: Single-center analyses of 37 cases","volume":"300","author":"Ebner","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejogrb.2006.07.025","article-title":"Pelvic exenteration for primary and recurrent gynaecological malignancies","volume":"134","author":"Logmans","year":"2007","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ygyno.2011.09.014","article-title":"Exenteration in the treatment of Stage III\/IV vulvar cancer","volume":"124","author":"Forner","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2021.10494","article-title":"Primary pelvic exenteration: Our experience with 23 patients from a single institution","volume":"22","author":"Gheorghe","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.21873\/cdp.10110","article-title":"Gynecologic Oncology: Pelvic Exenteration for Advanced or Recurring Cervical Cancer\u2014A Single Center Analysis","volume":"2","author":"Glane","year":"2022","journal-title":"Cancer Diagn. Progn."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"101702","DOI":"10.1016\/j.suronc.2021.101702","article-title":"Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece","volume":"40","author":"Haidopoulos","year":"2022","journal-title":"Surg. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ygyno.2024.07.674","article-title":"Perioperative outcomes in gynecologic pelvic exenteration before and after implementation of an enhanced recovery after surgery program","volume":"189","author":"Huepenbecker","year":"2024","journal-title":"Gynecol. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.3802\/jgo.2018.29.e68","article-title":"The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer","volume":"29","author":"Jalloul","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2009.09.035","article-title":"Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: Is still the clinical involvement of the pelvis wall a real contraindication? A twenty-year experience","volume":"116","author":"Jurado","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ygyno.2020.12.034","article-title":"Laparoscopic pelvic exenteration and laterally extended endopelvic resection for postradiation recurrent cervical carcinoma: Technical feasibility and short-term oncologic outcome","volume":"161","author":"Kanao","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ygyno.2011.09.031","article-title":"Pelvic exenteration with curative intent for recurrent uterine malignancies","volume":"124","author":"Einstein","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.4103\/0366-6999.235111","article-title":"Pelvic Exenteration for Recurrent and Persistent Cervical Cancer","volume":"131","author":"Li","year":"2018","journal-title":"Chin. Med. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ygyno.2009.03.029","article-title":"Pelvic exenteration: Ten-year experience at the European Institute of Oncology in Milan","volume":"114","author":"Maggioni","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_26","first-page":"69","article-title":"Survival rate and complications after different types of pelvic exenteration for gynecological cancer","volume":"40","author":"Nedyalkov","year":"2019","journal-title":"EJGO"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ygyno.2010.11.032","article-title":"Laparoscopic pelvic exenteration for gynaecological malignancy: Is there any advantage?","volume":"120","author":"Filleron","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ygyno.2019.02.002","article-title":"Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study","volume":"153","author":"Matsuo","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ygyno.2020.12.036","article-title":"Utilization and perioperative outcome of minimally invasive pelvic exenteration in gynecologic malignancies: A national study in the United States","volume":"161","author":"Matsuo","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/jso.25770","article-title":"Hospital surgical volume and perioperative mortality of pelvic exenteration for gynecologic malignancies","volume":"121","author":"Matsuo","year":"2019","journal-title":"J. Surg. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2010.11.044","article-title":"Pelvic exenteration in the age of modern chemoradiation","volume":"121","author":"McLean","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ygyno.2023.02.010","article-title":"Clinical outcomes of pelvic exenteration for gynecologic malignancies","volume":"171","author":"Moolenaar","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"PelvEx Collaborative (2019). Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy. Ann. Surg., 270, 899\u2013905.","DOI":"10.1097\/SLA.0000000000003533"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7819-12-279","article-title":"Surgical results of pelvic exenteration in the treatment of gynecologic cancer","volume":"12","author":"Petruzziello","year":"2014","journal-title":"World J. Surg. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1016\/j.jmig.2015.08.728","article-title":"Our experience of Laparoscopic Anterior Exenteration in Locally Advanced Cervical Carcinoma","volume":"22","author":"Gadkari","year":"2015","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2022.08.017","article-title":"A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenteration","volume":"167","author":"Filippova","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ygyno.2004.03.008","article-title":"Quality of life after pelvic exenteration","volume":"93","author":"Roos","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/ijgc-00009577-200507000-00008","article-title":"Pelvic exenteration as treatment of recurrent or advanced gynecologic and urologic cancer","volume":"15","author":"Roos","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ygyno.2016.10.018","article-title":"Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study","volume":"143","author":"Seagle","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000296300","article-title":"The Role of Exenterative Surgery and Urinary Diversion in Persistent or Locally Recurrent Gynecological Malignancy: Complications and Survival","volume":"85","author":"Spahn","year":"2010","journal-title":"Urol. Int."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Stanca, M., C\u0103p\u00eelna, D.M., and C\u0103p\u00eelna, M.E. (2022). Long-Term Survival, Prognostic Factors, and Quality of Life of Patients Undergoing Pelvic Exenteration for Cervical Cancer. Cancers, 14.","DOI":"10.3390\/cancers14092346"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1385\/MO:23:2:219","article-title":"Pelvic Exenteration for Recurrent or Persistent Cervical Cancer: Experience of Five Years at the National Cancer Institute in Mexico","volume":"23","year":"2006","journal-title":"Med. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00404-009-1175-0","article-title":"Evaluation of pelvic posterior exenteration in the management of advanced-stage ovarian cancer","volume":"281","author":"Tixier","year":"2009","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ygyno.2018.10.036","article-title":"Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies","volume":"152","author":"Tortorella","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.3802\/jgo.2024.35.e4","article-title":"Predictive factors of surgical complications after pelvic exenteration for gynecological malignancies: A large single-institution experience","volume":"35","author":"Tortorella","year":"2024","journal-title":"J. Gynecol. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00464-015-4172-3","article-title":"Initial experience of laparoscopic pelvic exenteration and comparison with conventional open surgery","volume":"30","author":"Uehara","year":"2015","journal-title":"Surg. Endosc."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.ygyno.2008.07.041","article-title":"Primary pelvic exenteration in cervical cancer patients","volume":"111","author":"Ungar","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Van Trappen, P., Walgraeve, M.-S., Roels, S., Claes, N., De Cuypere, E., Baekelandt, F., and Arentsen, H. (2024). Robotic-Assisted Pelvic Exenteration for Cervical Cancer: A Systematic Review and Novel Insights into Compartment-Based Imaging. J. Clin. Med., 13.","DOI":"10.3390\/jcm13133673"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ygyno.2014.06.034","article-title":"Overall survival after pelvic exenteration for gynecologic malignancy","volume":"134","author":"Westin","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3802\/jgo.2012.23.4.242","article-title":"Pelvic exenteration for recurrent cervical cancer: Ten-year experience at National Cancer Center in Korea","volume":"23","author":"Yoo","year":"2012","journal-title":"J. Gynecol. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-024-11836-3","article-title":"Long-term outcomes of pelvic exenterations for gynecological malignancies: A single-center retrospective cohort study","volume":"24","author":"Yu","year":"2024","journal-title":"BMC Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1245\/s10434-019-07817-7","article-title":"Extended Radical Resection: The Standard of Care for Patients with Advanced Pelvic Malignancy","volume":"27","author":"Solomon","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/codi.16844","article-title":"Variation in outcome measurement and reporting in studies of pelvic exenteration for locally advanced and recurrent rectal cancer: A systematic review","volume":"26","author":"Brown","year":"2023","journal-title":"Color. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Brown, K.G.M., Solomon, M.J., Koh, C.E., Sutton, P.A., Aguiar, S., Bezerra, T.S., Clouston, H.W., Desouza, A., Dozois, E.J., and Ersryd, A.L. (2024). Defining Benchmarks for Pelvic Exenteration Surgery: A Multicentre Analysis of Patients with Locally Advanced and Recurrent Rectal Cancer. Ann. Surg., Online ahead of print.","DOI":"10.1097\/SLA.0000000000006348"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/18\/3049\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:47:41Z","timestamp":1760035661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/18\/3049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":54,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cancers17183049"],"URL":"https:\/\/doi.org\/10.3390\/cancers17183049","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]}}}